Subscribe to RSS
DOI: 10.1055/s-2007-990847
Convergent or Linear? A Challenging Question in Carbocyclic Nucleoside Chemistry
Publication History
Publication Date:
29 October 2007 (online)
Abstract
North-methanocarbathymidine (N-MCT) is a carbocyclic nucleoside analogue with potent anti-HSV and KSHV activity. The critical step in the synthesis of N-MCT and other carbocyclic nucleoside analogues is the introduction of the nucleobase into the carbocyclic moiety. For this, convergent and linear strategies were compared side by side. In the convergent approach, the base was coupled to the carbocyclic moiety by either a Mitsunobu reaction or by displacement of a mesylate. This strategy leads to the formation of various amounts of the O 2-regioisomer, depending on the applied procedure. Additionally, by-products of the Mitsunobu reaction have to be separated from the coupling products. Although lengthier, the linear strategy leads selectively to the target compound N-MCT with overall yields comparable to the convergent approaches, making this strategy more compatible for future large-scale syntheses.
Key words
medicinal chemistry - nucleosides - carbocycles - Mitsunobu reaction - regioselectivity
- For reviews on the synthesis of carbocyclic nucleosides, see:
-
1a
Borthwick AD.Biggadike K. Tetrahedron 1992, 48: 571 -
1b
Agrofoglio L.Suhas E.Farese A.Condom R.Challand SR.Earl RA.Guedj R. Tetrahedron 1994, 50: 10611 -
1c
Crimmins MT. Tetrahedron 1998, 54: 9229 -
1d
Zhu XF. Nucleosides, Nucleotides Nucleic Acids 2000, 19: 651 - For selected reviews on biological properties of nucleoside analogues, see:
-
2a
Nucleosides and Nucleotides as Antitumor and Antiviral Agents
Chu CK.Baker DC. Plenum Press; New York: 1993. -
2b
De Clercq E. Ann. N. Y. Acad. Sci. 1994, 724: 438 -
2c
Nair V.Jahnke TS. Antimicrob. Agents Chemother. 1995, 39: 1017 -
2d
Wilson LJ.Hager MW.El-Kattan YA.Liotta DC. Synthesis 1995, 1465 -
2e
Chu CK. Nucleic Acids Symp. Ser. 1996, 35: 1 -
2f
Marquez VE. In Advances in Antiviral Drug Design Vol. 2:De Clercq E. JAI Press; Greenwich: 1996. p.89 -
2g
Mitsuya H. In Anti-HIV Nucleosides: Past, Present and Future Landes; Texas: 1997. -
2h
Pan S.Amankulor NM.Zhao K. Tetrahedron 1998, 54: 6587 -
2i
Agrogoglio LA.Challand SR. In Acyclic, Carbocyclic and l -Nucleosides Kluwer Academic Publishers; Dordrecht: 1998. -
2j
Simons C. In Nucleoside Mimetics: Their Chemistry and Biological Properties Gordon and Breach Science Publishers; New York: 2001. - 3
Marquez VE.Hughes SH.Sei S.Agbaria R. Antiviral Res. 2006, 71: 268 -
4a
Rodriguez JB.Marquez VE.Nicklaus MC.Barchi JJ. Tetrahedron Lett. 1993, 34: 6233 -
4b
Altmann KH.Kesselring R.Francotte E.Rihs G. Tetrahedron Lett. 1994, 35: 2331 -
4c
Rodriguez JB.Marquez VE.Nicklaus MC.Mitsuya H.Barchi JJ. J. Med. Chem. 1994, 37: 3389 - 5
Altona C.Sundaralingam M. J. Am. Chem. Soc. 1972, 94: 8205 -
6a
Marquez VE.Ezzitouni A.Russ P.Siddiqui MA.Ford H.Feldman RJ.Mitsuja H.George C.Barchi JJ. J. Am. Chem. Soc. 1998, 120: 2780 -
6b
Marquez VE.Russ P.Alonso R.Siddiqui MA.Hernandez S.George C.Nicklaus MC.Dai F.Ford H. Helv. Chim. Acta 1999, 82: 2119 -
6c
Kim HS.Ravi RG.Marquez VE.Maddileti S.Wihlborg A.-K.Erlinge D.Malmsjö M.Boyer JL.Harden TK.Jacobson KA. J. Med. Chem. 2002, 45: 208 -
6d
Marquez VE.Ben-Kasus T.Barchi JJ.Green KM.Nicklaus MC.Agbaria R. J. Am. Chem. Soc. 2004, 126: 543 -
6e
Marquez VE.Choi Y.Comin MJ.Russ P.George C.Huleihel M.Ben-Kasus T.Agbaria R. J. Am. Chem. Soc. 2005, 127: 15145 -
6f
Comin MJ.Agbaria R.Ben-Kasus T.Huleihel M.Liao C.Sun G.Nicklaus MC.Deschamps JR.Parrish DA.Marquez VE. J. Am. Chem. Soc. 2007, 129: 6216 -
7a
Marquez VE.Siddiqui MA.Ezzitouni A.Russ P.Wang J.Wagner RW.Matteucci MD. J. Med. Chem. 1996, 39: 3739 -
7b
Ezzitouni A.Marquez VE. J. Chem. Soc., Perkin Trans. 1 1997, 1073 -
7c
Russ P.Schelling P.Scapozza L.Folkers G.De Clercq E.Marquez VE. J. Med. Chem. 2003, 46: 5045 -
8a
Zalah L.Huleihel M.Manor E.Konson A.Ford H.Marquez VE.Johns DG.Agbaria R. Antiviral Res. 2002, 55: 63 -
8b
Huleihel M.Talishanisky M.Ford H.Marquez VE.Kelley JA.Johns DG.Agbaria R. Int. J. Antimicrob. Agents 2005, 25: 427 - 9
Zhu W.Burnett A.Dorjsuren D.Roberts PE.Huleihel M.Shoemaker RH.Marquez VE.Agbaria R.Sei S. Antimicrob. Agents Chemother. 2005, 49: 4965 - 10
Boyer PL.Julias JG.Marquez VE.Hughes SH. J. Mol. Biol. 2005, 345: 441 -
11a
Moon HR.Ford H.Marquez VE. Org. Lett. 2000, 2: 3793 -
11b
Yoshimura Y.Moon HR.Choi Y.Marquez VE. J. Org. Chem. 2002, 67: 5938 - 12
Cruickshank KA.Jiricny J.Reese CB. Tetrahedron Lett. 1984, 25: 681 - 13
.
Zanilpa SA.Guzman A.Morgans DJ. Synth. Commun. 2001, 31: 3739 -
14a
Mitsunobu O. Synthesis 1981, 1 -
14b
Hughes DL. Org. React. 1993, 42: 335 -
15a
Jenny TF.Previsani N.Benner SA. Tetrahedron Lett. 1991, 32: 7029 -
15b
Jenny TF.Horlacher J.Previsani N.Benner SA. Helv. Chim. Acta 1992, 75: 1944 -
16a
Choo H.Chong Y.Chu CK. Org. Lett. 2001, 3: 1471 -
16b
Ludek OR.Meier C. Synlett 2006, 324 -
17a
Schmitt L.Caperelli CA. Nucleosides Nucleotides 1997, 16: 2165 -
17b
Ludek OR.Meier C. Eur. J. Org. Chem. 2006, 941 -
18a
Bonnal C.Chavis C.Lucas M. J. Chem. Soc., Perkin Trans. 1 1994, 1401 -
18b
Ludek OR.Meier C. Synlett 2005, 3145 - 19
Borthwick AD.Crame AJ.Exall AM.Weingarten GG.Mahmoudian M. Tetrahedron Lett. 1995, 36: 6929 -
20a
Ludek OR.Meier C. Synthesis 2003, 2101 -
20b
Ludek OR.Krämer T.Balzarini J.Meier C. Synthesis 2006, 1313 - For reviews on atom economy, see:
-
21a
Trost BM. Angew. Chem., Int. Ed. Engl. 1995, 34: 259 -
21b
Trost BM. Acc. Chem. Res. 2002, 35: 695 - In recent years many strategies were developed to encounter these drawbacks, including solid-phase chemistry and modified reagents that extract into aqueous media. For reviews on simplified workup procedures, see:
-
22a
Dembinski R. Eur. J. Org. Chem. 2004, 2763 -
22b
Dandapani S.Curran DP. Chem. Eur. J. 2004, 10: 3130 -
23a
Harnden MR.Jarvest RL.Bacon TH.Boyd MR. J. Med. Chem. 1987, 30: 1636 -
23b
Choudary BM.Geen GR.Kincey PM.Parratt MJ. Nucleosides Nucleotides 1996, 15: 981 -
24a
Slusarchyk WA.Young MG.Bisacchi GS.Hockstein RR.Zahler R. Tetrahedron Lett. 1989, 30: 6453 -
24b
Borcherding DR.Peet NP.Munson HR.Zhang H.Hoffman PF.Bowlin TL.Edwards CK. J. Med. Chem. 1996, 39: 2615 -
25a
Baumgartner H.Marschner C.Pucher R.Griengl H. Tetrahedron Lett. 1991, 32: 611 -
25b
Ueno Y.Karino N.Matsuda A. Bioconjugate Chem. 2000, 11: 933 -
26a
Pelissier H.Rodriguez J.Vollhardt KPC. Chem. Eur. J. 1999, 5: 3549 -
26b
Paryzek Z.Tabaczka B. Org. Prep. Proced. Int. 2001, 33: 400 -
26c
Howarth NM.Wakelin LPG.Walker DM. Tetrahedron Lett. 2003, 44: 695 -
26d
Young JEP.Horenstein NA. Tetrahedron Lett. 2004, 45: 9505 -
27a
Zook HD.Gumby WL. J. Am. Chem. Soc. 1960, 82: 1386 -
27b
Cacciapaglia R.Mandolini V. J. Org. Chem. 1988, 53: 2579 - 29
Reichardt C. Solvents and Solvent Effects in Organic Chemistry 2nd ed.: VCH; Weinheim: 1988. - 30
Bodenteich M.Griengl H. Tetrahedron Lett. 1987, 44: 5311
References
The ammonium salts were prepared prior to the reaction by adding stoichiometric amounts of either tetramethylam-monium or tetrabutylammonium hydroxide to the BOM-protected heterocycle 4 in water. The obtained solutions were lyophilized and the crude salts were used without any further purification.